Management and Follow-up of Patients with a Bronchial Neuroendocrine Tumor in the Last Twenty Years in Ireland: Expected Inconsistencies and Unexpected Discoveries

Table 6

Therapeutic management of bronchial NET patients managed at our institution divided in chronological time frames.

	1995–2000	2001–2005	2006–2010	2011–2015
	Surgery	5 (100%)	2 (100%)	20 (95.2%)	17 (89.5%)
Somatostatin analogs	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Interferon alpha	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Peptide receptor radionuclide therapy	0 (0%)	0 (0%)	0 (0%)	0 (0%)
Radiotherapy	0 (0%)	0 (0%)	0 (0%)	1 (5.3%)
Chemotherapy	0 (0%)	0 (0%)	0 (0%)	1 (5.3%)
Locoregional therapy of distant metastases (radiofrequency ablation, chemoembolization)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
No treatment	0 (0%)	0 (0%)	0 (0%)	1 (5.3%)

: number of patients.